T he projected number of patients with a history of cancer in the United States is expected to increase from 13.7 million in 2012 to 18 million by 2022, with a 37% increase for those who will live 5 or more years after diagnosis. 1 The fragmentation of posttherapy care often leads to uncertainty on who is responsible for managing anxiety as well as other psychosocial needs.
Anxiety disorders, as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth
Edition, share features of excessive fear and anxiety. While fear is the response to an imminent threat, anxiety is anticipation of future threat manifesting as excessive and persistent fear or worry. 2 Attention to anxiety is an important psychosocial aspect of cancer survivorship care. 3, 4 The prevalence of anxiety is higher in survivors of cancer compared to healthy controls, and this difference persists in patients whose cancer was diagnosed 10 or more years previously. 5 Anxiety can negatively impact quality of life in cancer survivors, 6 impacting mental health and functioning and increasing the severity of somatic symptoms. 7 In 2008, the Institute of Medicine reported that addressing psychosocial needs of patients is part of quality cancer care. 8 Current American Society of Clinical Oncology (ASCO) guidelines state that all health providers should routinely screen patients with cancer and survivors for anxiety. 9 Less than half of survivors report having a discussion about psychosocial needs with a health care provider. 10 Discussing psychosocial needs helps identify otherwise undetected needs and provides an opportunity for treatment or referral for those needs. 10 Previous work has found that more than half of survivors report fear of recurrence even years after cancer diagnosis. 11 Increased anxiety in these participants influenced their decisions, which may affect their quality of life. 12 Survivors' reported quality of life at 1, 3, and 5 years after diagnosis showed a perceived decrease in all domains, particularly with regard to anxiety and depression. 6, 13, 14 Arrieta et al reported an association between depression and poor treatment adherence in patients with lung cancer. 15 Literature from other life-altering diseases noted a deleterious effect of anxiety on quality of life in patients on dialysis and those who received kidney transplants. [15] [16] [17] In patients with cancer, Mutsaers et al differentiated when fear of cancer recurrence becomes clinical. 18 It is here where cancer survivors benefit from therapy. 19 As the number of survivors increases and past patients become more removed in time and geography from their initial cancer treatment, primary care providers (PCP) are well placed to address and manage anxiety within this patient population. 20 Studies of cancer survivorship trajectories identify different pathways for cancer-related worry and posttraumatic growth. 19 This includes adapting care, including the diagnosis and management of anxiety that often occurs. 21 PCPs are experienced in adapting therapy to patient needs.
The purpose of this study was to examine patient opinions about where and which health care provider group should diagnose and address anxiety-related issues in cancer survivorship. Our theoretical framework leans on the work of Martin et al and Ratcliff et al, in which cancer survivorship is described as a trajectory. 12, 19 Of importance, the provider must not only assess whether anxiety or depression is present but determine whether it is clinically significant and warrants intervention. 18 We are particularly interested in the current and potential roles of PCPs in survivorship care along this patientcentered trajectory.
METHODS
After institutional review board approval was obtained in April 2017, a mass email message (N=22,000) was distributed to the University of Iowa campus community once. Convenience sampling was used for the focus groups. 22 Participants were then selected on a first-come first-served basis. Participants included patients who met the following eligibility criteria: 1) adult patient greater than 25 years old; 2) history of cancer diagnosis; and 3) at least 18 months from completion of definitive cancer therapy, including radiation, surgery, or chemotherapy. After participation in the focus group, a $20 gift card was provided to participants to partially compensate them for their time.
Two-hour focus groups of posttreatment cancer survivors were conducted in a conference room at the University of Iowa Health Care's Department of Family Medicine (Iowa City, IA). This provided a neutral space for the focus groups. 23 At each focus group, participants were initially asked to briefly introduce themselves and describe their unique experience with cancer. The moderator (M.B-S., female) then used targeted questions and prompts to ensure specific issues guided the focus group interviews. 23 These issues included the role of the PCP during and after cancer therapy, the transition to primary care after therapy was finished, and advice the study participants would give to PCPs and survivors of cancer. With the consent of the participants, focus groups were audio-recorded and 2 designated notetakers were present at each meeting. 23 The recordings were later transcribed and reviewed by members of the research team (1 family physician, 2 medical students, and 1 research scientist).
Transcripts were read and coded separately by 4 different members of the research team. The raw coding techniques used by the researchers varied from line-by-line gerund coding to thematic coding. 24 Table 1 shows the code book used and applied to the transcripts. After the initial coding was completed, discussions about emerging themes took place. All data relevant to anxiety were then extracted. The constant comparison method was used, for a total of 2 cycles, with each coder to make comparisons within and between transcripts in order to identify common themes with respect to anxiety. 24 
RESULTS
We conducted 3 focus groups totaling 20 women and 2 men, with ages ranging from the 30s to the 70s. Time since treatment ranged from 18 months to many years. Cancer types among the participants included breast, prostate, testicular, non-Hodgkin's lymphoma, osteosarcoma, ovarian, thyroid, uterine, fallopian tube, melanoma, and vaginal. Of the 22 participants, 7 had either the same type of recurring cancer or were survivors of multiple cancer types.
The survivors in our focus groups described anxiety persisting through cancer diagnosis, treatment, and well into survivorship. Participants discussed anxiety surrounding many facets of their lives. We found 5 main themes related to anxiety: the memory of anxiety, anxiety related to possible cancer recurrence, the role of the provider in management of anxiety, the importance of communication, and the influence of anxiety on future health decisions.
Memory of Anxiety
Participants discussed experiencing anxiety during the survivorship phase as a result of the anxiety experienced during cancer diagnosis and treatment. Participants even compared the anxiety felt during the survivorship phase as similar to posttraumatic stress disorder (PTSD), a condition that causes patients to be distressed by the mental recollection of past traumatic events. While the participants did not specifically disclose whether they had a medical diagnosis of anxiety disorder or PTSD, the term PTSD was mentioned by more than one participant. They described the memory of anxiety associated with the cancer diagnosis and treatment as strong enough to evoke intense anxiety years after cancer treatment was completed. 
Role of Health Care Provider (Primary Care or Oncologist) in Anxiety Management
Participants had differing opinions as to which provider was best equipped to manage anxiety. Some participants expressed having a close relationship with their oncologists. There was more trust in the oncologist compared to other providers due to knowledge of the cancer and treatment course. These participants felt more comfortable going directly to their oncologists with health concerns, including anxiety, and had difficulty trusting other providers "Anytime there was kind of, if I had a worrisome symptom, I would have gone back to see my oncologist."
Other participants described a close relationship with their PCP. These participants felt their PCP had deeper insight into aspects of care, such as mental health and anxiety, when compared to the oncologist. Participants described struggling with anxiety and other mental health issues that went unnoticed by oncology providers. In these situations, the PCP was able to assess and treat the concerns. Participants expressed feeling more comfortable in talking about mental health with the PCP. "I was on antidepressants and anti-anxiety meds, so my primary care doctor was really helpful with this. It was pretty stressful and depressing, and anxiety-producing. So he kept, um, he kept me going and adjusted the medications for me."
Communication Reduced Anxiety Symptoms
Anxiety was often coupled with communication during the focus group discussions. Participants described increased communication helped to decrease anxiety. They shared having access to a provider helped to relieve anxiety, while no access became a source of anxiety. The main forms of access discussed were phone calls and emails. Lack of access left participants feeling isolated and alone, which led to increased anxiety. 
DISCUSSION
For the survivors of cancer in our focus groups, anxiety was a common condition through all the phases of their cancer care -diagnosis, treatment, and survivorship. The memory of the anxiety felt while going through the process of cancer diagnosis and treatment was still felt years after treatment completion. Some participants described PTSD-like feelings in looking back on their experience. Intrusive symptoms associated with the traumatic event start long after the event occurs. These include distressing memories, recurrent dreams, flashbacks, or other similar symptoms. Firmin et al addressed triggering events as generating events. 2, 14 A positive correlation has been reported between survivors of cancer and PTSD. 25 Our research demonstrates the memory of anxiety in survivors of cancer continues to have an impact after treatment is completed. This is in line with previous research showing the prevalence of anxiety is greater in survivors of cancer versus healthy controls. 5 Some participants preferred oncologists to provide anxiety-related care, whereas others preferred the PCP. Often, oncologists and PCPs also will have differing opinions on who should be providing what type of care for survivors of cancer. 26 Ongoing care includes general health maintenance, which would cover mental health and anxiety. 27 However, a 2004 survey of ASCO members showed that only 61.2% of its members reported feeling comfortable providing general medical care to survivors. 28 On the other hand, both patients and general practitioners support a greater role for the general practitioner in followup cancer care. 21 Regardless of which provider addressed anxiety, participants found relief if anxiety was addressed. Current ASCO guidelines state that all providers should screen for anxiety from the time of cancer diagnosis and onward. 9 Our research showed this is not always the case for cancer survivors; however, addressing anxiety is exceedingly important as the relative risk of anxiety is statistically significant 10 or more years after the cancer diagnosis. 5 A study into long-term follow-up duration with oncology in pediatric cancer patients showed less than 50% of pediatric patients received follow-up care from oncology 10 years after treatment. 29 Family physicians are an important component of follow-up care, particularly for cancers with extended posttherapy survival, such as breast, prostate, and those with a history of childhood cancer. [30] [31] [32] [33] [34] Consistent with previous research, our study showed that anxiety is an ongoing challenge for survivors of cancer along the survivorship timeline. 19, 35 Our findings also identified where patients successfully find care for their anxiety and explored how patients want their anxiety addressed. The subthemes identified under anxiety included the memory of anxiety, possible cancer recurrence, the role of the provider in anxiety management, extent of communication, and the influence of anxiety on future health decisions. Anxiety was discussed by most participants, particularly the need to address and manage this concern. The focus group data support a role for primary care in assessing and managing anxiety for survivors of cancer. The data also underscore the need for improved communication between all stakeholders, including oncologists, PCPs, and patients, to enhance the quality of care received by survivors of cancer.
Focus groups showed participants felt increased anxiety when communication was decreased. One way to combat this anxiety is discussing survivorship care. According to Blanch-Hartigan et al, 64% of oncologists reported discussing survivorship care recommendations with survivors while only 32% of oncologists reported discussing who the survivor should see for cancer-related or other follow-up care. 36 These low percentages are reflected in the anxiety expressed by participants in the focus groups. Anxiety has been described as an unmet need, since less than half of the survivors report a discussion with a provider about psychosocial needs. 10 This underscores the importance of addressing anxiety in survivors of cancer, 13, 19 as some participants described intense anxiety, and further emphasizes the need for anxiety screening and treatment in this growing patient population. 1
Limitations
While symptoms and issues related to anxiety were reported by focus group participants, we do not know how many patients were diagnosed with anxiety disorder. Anxiety related to specific types of cancer diagnosis and stage were not explored. Our results do not provide information on which of the 5 main themes should be prioritized in the clinical setting.
Future areas of study for this topic include a more in-depth investigation into anxiety screening and treatment modalities available to cancer survivors in the primary care setting. Additional work might entail the development of evidence-based interventions for different survivorship trajectories based on expression of the anxiety/depression themes and the clinical severity. This would most likely involve a multimodal approach consisting of traditional pharmacologic, behavioral, and cognitive therapies as well as new methods such as the internet-based cognitive behavioral therapy studied by Karageorge and colleagues. 37
CONCLUSIONS
The survivors of cancer who participated in our focus group described anxiety as a significant condition and part of their cancer experience that persisted throughout diagnosis, treatment, and well into survivorship. Cancer survivorship trajectories are not one-size-fits-all, and the associated "best therapy" will be multifactorial. Primary care providers should be well trained to manage anxiety in cancer survivorship. Patients continue to go to their PCP for medical care after cancer diagnosis and therapy, thus PCPs may be best poised to improve the quality of cancer survivorship care as it pertains to alleviating anxiety.
Patient-Friendly Recap
• Millions of cancer survivors live longer than 5 years after their cancer treatment ends, yet how anxiety is best managed during extended survivorship is unknown.
• Through focus group interviews, the authors identified 5 main issues related to anxiety: 1) memory of anxiety lingers for years; 2) possibility of cancer recurrence induces anxiety; 3) relationship with health care provider impacts anxiety management; 4) frequency of communication can reduce anxiety symptoms; and 5) anxiety affects future health decisions.
• The authors suggest that, while different patient survivorship trajectories require different approaches to care, primary care providers should be well positioned to manage appropriate anxiety therapy for cancer survivors.
